TABLE 3.

mRNA in clinical trials.

Name	Disease	Target	ClinicalTrials.gov Identifier	Recruitment Status	Phase	Reference
mRNA-1273	COVID-19 vaccine	Spike (S) protein of SARS-CoV-2	NCT04283461	Active	I	Jackson et al. (2020)
BNT162b1	COVID-19 vaccine	RBD of Spike glycoprotein	NCT04368728	Recruiting	I	Mulligan et al. (2020)
mRNA-4157	Vaccine	Multiple neoantigens	NCT03313778	Recruiting	I	Burris et al. (2019)
Lipo-MERIT	Melanoma	Melanoma-associated antigens	NCT02410733	Active	I	(Jabulowsky et al., 2018; Sahin et al., 2020)
CV7201	Rabies	Rabies virus glycoprotein	NCT02241135	Completed	I	Alberer et al. (2017)
VAL-506440	Influenza	H10N8 Antigen	NCT03076385	Completed	I	Feldman et al. (2019)
VAL-339851		H7N9 antigen	NCT03345043	Active	I
AZD8601	Type II Diabetes	VEGF-A	NCT02935712	Completed	I	Gan et al. (2019)
	Heart Failure		NCT03370887	Recruiting	II	Anttila et al. (2020)